Short-acting beta(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

Creative Commons License

Yorgancioglu A., Aksu K., NAYCI S., EDİGER D., Mungan D., Gul U., ...More

BMC PULMONARY MEDICINE, vol.22, no.1, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.1186/s12890-022-02008-9
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Keywords: Asthma, Exacerbations, Turkey, Prescriptions, Short-acting beta(2)-agonists, PREVALENCE, SEVERITY, OBESITY, IMPACT
  • Bursa Uludag University Affiliated: Yes


Background: Over-reliance on short-acting beta(2)-agonists (SABAs) is associated with poor asthma outcomes. However, the extent of SABA use in Turkey is unclear owing to a lack of comprehensive healthcare databases. Here, we describe the demographics, disease characteristics and treatment patterns from the Turkish cohort of the SABA use IN Asthma (SABINA) III study.